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The Global Programme to Eliminate Lymphatic Filariasis uses point-of-care tests for circu-
lating filarial antigenemia (CFA) to map endemic areas and for monitoring and evaluating
the success of mass drug administration (MDA) programs. We compared the performance
of the reference BinaxNOW Filariasis card test (ICT, introduced in 1997) with the Alere Fila-
riasis Test Strip (FTS, introduced in 2013) in 5 endemic study sites in Africa.
Methodology
The tests were compared prior to MDA in two study sites (Congo and Coˆte d’Ivoire) and in
three sites that had received MDA (DRC and 2 sites in Liberia). Data were analyzed with
regard to % positivity, % agreement, and heterogeneity. Models evaluated potential effects
of age, gender, and blood microfilaria (Mf) counts in individuals and effects of endemicity
and history of MDA at the village level as potential factors linked to higher sensitivity of the
FTS. Lastly, we assessed relationships between CFA scores and Mf in pre- and post-MDA
settings.
Principal findings
Paired test results were available for 3,682 individuals. Antigenemia rates were 8% and
22% higher by FTS than by ICT in pre-MDA and in post-MDA sites, respectively. FTS/ICT
ratios were higher in areas with low infection rates. The probability of having microfilaremia
was much higher in persons with CFA scores >1 in untreated areas. However, this was not
true in post-MDA settings.
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Conclusions/Significance
This study has provided extensive new information on the performance of the FTS com-
pared to ICT in Africa and it has confirmed the increased sensitivity of FTS reported in prior
studies. Variability in FTS/ICT was related in part to endemicity level, history of MDA, and
perhaps to the medications used for MDA. These results suggest that FTS should be supe-
rior to ICT for mapping, for transmission assessment surveys, and for post-MDA
surveillance.
Author summary
The Global Programme to Eliminate Lymphatic Filariasis (LF) uses point-of-care tests for
circulating filarial antigenemia to map endemic areas and for monitoring and evaluating
the success of mass drug administration (MDA) programs. We compared the perfor-
mance of the reference BinaxNOW Filariasis card test (ICT) with the Alere Filariasis Test
Strip (FTS, introduced in 2013) in 3,682 people in 5 endemic study sites in Africa. Our
study confirmed the increased sensitivity of FTS reported in prior studies. FTS/ICT ratios
tended to be higher in areas with low residual endemicity after MDA. However, FTS rates
were only slightly higher than ICT rates in young children. These results suggest that FTS
should be superior to ICT as a tool for mapping and for monitoring and evaluating LF
elimination programmes.
Introduction
Lymphatic filariasis (LF) is a major neglected tropical disease (NTD) that the World Health
Organization (WHO) has targeted for elimination by 2020 [1]. The Global Programme to
Eliminate Lymphatic Filariasis (GPELF, launched in 2000) uses repeated rounds of mass drug
administration (MDA) with antifilarial drugs to interrupt transmission of the parasite. In
2015, MDA programs were active in 45 countries, and plans were being made to launch MDA
in 6 other countries [2].
The first point of care (POC) test for circulating filarial antigenemia (CFA) was introduced
in the late 1990s, and antigen tests have been used in GPELF since it started in 2000. CFA tests
detect a 200 kDa Wuchereria bancrofti adult worm product [3]. Antigen testing is more sensi-
tive for filarial infection than tests that detect microfilariae (Mf) in night blood. POC antigen
tests can be performed with finger prick blood collected during the day or night, and they pro-
vide a visual result in 10 minutes [4,5]. They include the BinaxNOW Filariasis card test (Alere,
Scarborough, ME) [6], which is an immunochromatographic card test (ICT) used by the
GPELF since 2000, and the Alere Filariasis Test Strip (FTS) that was introduced in 2013. ICT
card tests have been very useful for LF elimination programs, because they can be used to test
people during the day or night while Mf testing requires night blood testing in most endemic
areas. However, in settings in the tropics with limited resources, the FTS has several important
advantages over the ICT. It is less costly, it has a longer shelf life, and it has greater analytical
sensitivity (a lower limit of detection) [7].
ICT card tests or FTS are widely used during each step of LF elimination programs [8].
First, the tests can be used for mapping endemicity and determining whether implementation
units require MDA. Antigen testing can also be used as an alternative to microfilaria testing to
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show that MDA has reduced infection rates in sentinel and spot-check sites prior to perfor-
mance of transmission assessment surveys (so called “pre-TAS” surveys). Antigen tests are
used for TAS surveys that are used to decide on whether to continue or stop MDA. TAS sur-
veys are also used for post-MDA surveillance.
Two published studies compared the performances of the ICT and FTS tests. One tested 519
subjects living in a LF endemic area in Liberia that had received one prior round of MDA with
ivermectin (IVM) alone for onchocerciasis [7]. Filarial antigenemia rates by ICT and the FTS in
this area were 19.3% and 24.7%, respectively, and the FTS/ICT ratio (number of positive FTS
divided by the number of positive ICT for people with valid results for both tests) was 1.28.
Twenty-seven of 124 FTS positive subjects were ICT negative while only one of 98 ICT positive
individuals was negative by FTS. The second study was conducted in 2014 in areas in Sri Lanka
where MDA with albendazole (ALB) and diethylcarbamazine (DEC) had been distributed
between 2002 to 2006 (number of participants: 852), and in one village in central Java (Indone-
sia) where the same combination was used between 2011 and 2014 (778 participants) [9]. Again,
FTS was found to be more sensitive than ICT for detecting filarial antigenemia. However, FTS/
ICT ratios differed markedly between the two sites (1.22 in Indonesia and 2.33 in Sri Lanka).
Since hundreds of thousands of ICT have been performed during GPELF already and many
more FTS are expected to be performed in the near future, it is essential to understand the rela-
tive performance of these tests in a broad variety of epidemiological settings. In this context,
the present study compared the performance of the FTS and ICT tests in five study sites
located in four African countries. The study populations had varied filarial infection rates and
varied prior exposure to MDA for LF.
Methods
Study areas and subjects
The studies were performed in West Africa (Liberia and Coˆte d’Ivoire) and Central Africa
(Republic of Congo and Democratic Republic of Congo).
Republic of Congo (“Congo”). The study was performed in Se´ke´ Pembe´, a village located
in a savanna area of the Bouenza division where a community trial was conducted to assess the
impact of semiannual community treatments with ALB alone on LF. The pre-trial (2012) preva-
lence of antigenemia in the population aged5 years (773 subjects tested), measured using
ICT, was 17.3%. The comparative study of the ICT and FTS was performed with 697 partici-
pants in October 2014, after four rounds of MDA (October 2012, April and October 2013 and
April 2014). Other aspects of this study have already been described in detail previously [10,11].
Democratic Republic of Congo (DRC). The study was performed on 187 residents of
Misaie, a village located in the Bagata territory of Kwilu Province. This village is located in a
savanna area on the right bank of the Kwilu River approximately 300 km north-east of Kin-
shasa. Misaie village is also a study site of the impact of community MDA with ALB on LF.
The data reported here come from a survey that was conducted in June 2014, just prior to the
first round of MDA.
Liberia. Two sites were studied in Liberia. One study was performed in 9 villages in Foya
district, Lofa county (681 subjects tested), in the north-western part of the country. This area is
also endemic for onchocerciasis, and community-directed treatments with IVM (CDTI) had
been irregularly provided there since 2000. A baseline survey completed in September 2012
revealed an antigenemia prevalence (by ICT) of 19.3%. MDA with ALB and IVM was provided
in November 2012 (school children also received praziquantel) and in June 2013 with ALB,
IVM and praziquantel (offered to all 5 years of age), as part of a study to assess the impact
and cost-effectiveness of annual and biannual MDA on onchocerciasis and LF. In the present
Comparison of ICT and FTS tests for Wuchereria bancrofti antigenemia in Africa
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005703 September 11, 2017 3 / 15
study most villages were located in the area that received twice yearly MDA, and only two vil-
lages (Foya Dundu and Foya Town) received once yearly MDA. The comparison of ICT and
FTS results was performed in February-April 2014 with participants selected from ten villages.
The second study in Liberia was conducted in Harper district (Maryland county, 1,149 sub-
jects tested), in the south-eastern part of the country which is endemic for LF and hypoen-
demic for onchocerciasis. A baseline prevalence survey was performed in April and May 2013
followed by MDA with ivermectin plus albendazole in May 2013 (all villages) and November
2013 (only in Little Wlebo, Rock Town, Easy Town, Fish Town, Whole Graway). The study to
compare ICT and FTS was performed in June 2014.
Coˆte d’Ivoire. The study was performed in Yadio and Soribadougou villages (968 subjects
tested) located in Lagunes District (Akoupe Division), that is endemic for both LF and oncho-
cerciasis. CDTI (ivermectin only) was provided for onchocerciasis prior to 2009 in these vil-
lages, but no MDA of any kind had been administered since that time when the antigen test
comparison study was conducted in 2014.
Antigen detection tests
CFA was detected by the Binax Filariasis Now card test (ICT) and by the Alere Filariasis Test
Strip (FTS) (both produced by Alere, Inc., Scarborough, ME) according to the manufacturer’s
instructions. Tests were read at 10 minutes by a single trained operator in the Central African
sites, and in the West Africa sites, ICT and FTS were read independently by a single trained
technician; two separate technicians read the tests in the West Africa study sites. These point-
of-care rapid diagnostic tests have two lines that are visible to readers. These include a control
(C) line (which is a procedural control required for the test to be valid), and a test (T) line
(which is visible for positive tests and absent in negative tests). Based on the assumption that
the FTS is more sensitive than ICT, and in order to prevent bias in reading, the operator in the
Central African sites read and scored ICT results before reading the FTS. In the very rare cases
of uncertain result, a second (Central Africa) or third (West Africa) reader was consulted to
reach a final decision. Since the intensity of antigen test lines is correlated with CFA levels
[12], the results were scored as previously described: 0 for tests with no visible test T line; 1
when the T line was weaker than the control C line; 2 when the T line was approximately as
dark as the C line; and 3 when the T line was darker than the C line [12,13].
Parasitological assessment
All individuals with positive ICT and/or FTS tests were asked to provide a second blood sam-
ple between 10:00 PM and 1:00 AM for assessment of W. bancrofti Mf. In West Africa, finger-
prick blood was collected in capillary tubes with EDTA anticoagulant, and this blood was used
to prepare Mf smears. In Central Africa, blood smears were directly prepared from blood col-
lected from the finger in capillary tubes without anticoagulant. In Congo and DRC, two rect-
angular (~ 15x30 mm) thick blood smears (TBS, 70 μL each) were prepared for each subject.
In Liberia and Coˆte d’Ivoire, a single three-line TBS (60 μL total blood volume) was prepared
per subject. On the next day, the TBS were dehemoglobinized, stained with Giemsa, and exam-
ined by two microscopists. In Congo and DRC each microscopist read one of the two slides
from each subject. In Liberia and Coˆte d’Ivoire a single microscopist read the slides and 10%
of the slides were re-checked by a different microscopist for quality control. In the Central
Africa sites, the Mf count for individual subjects was defined as the arithmetic mean of the
counts made on the two slides and expressed as Mf/mL of blood. Mf counts in Liberia and
Coˆte d’Ivoire were calculated as Mf/mL based on the number of parasites counted on the
60 μL night blood slides.
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Statistical analyses
Only subjects with valid results for both tests were included in the analysis. The statistical sig-
nificance of differences in categorical and quantitative variables was assessed by the Chi-
squared test and the Kruskal-Wallis test, respectively.
A first set of analyses was performed at the community level to determine percent agree-
ments (proportion of blood samples that produced the same results with both CFA tests),
Cohen’s kappa (κ) coefficients, and FTS/ICT ratios. In contrast to percent agreement, the
Cohen’s κ coefficients are derived from a non-parametric statistical test that compares observed
and expected probabilities by categories [14]. A pooled Cohen’s κ estimate was calculated for
each group of villages according to the history of MDA (pre-MDA, post-MDA with ALB alone,
post-MDA with IVM+ALB). Post-MDA with DEC+ALB Cohen’s κ estimates were based on
published results from studies performed in Sri Lanka and Indonesia [9]. The calculation was
done using a model fitted using R package metafor (R software, version 3.2.3) [15]. This
included a random effect at the village level so that we could estimate heterogeneity (I2 index)
[16]. We also assessed differences between the distributions of ICT and FTS scores. Lastly, the
relationship between ICT prevalence rates and the FTS/ICT ratios was examined using data col-
lected in the study sites listed above and published data from Sri Lanka and Indonesia [9].
The second series of analyses, performed at the level of individual study subjects, used a
three-level logistic random-intercept model to explain the nature of the higher sensitivity of
FTS compared to ICT. These analyses only considered data from Africa, and the work focused
on subjects with a negative ICT result and a positive FTS result (“ICT-miss”). We considered
three variables for participants (age [five categories: 5–10, 11–20, 21–40, 41–60,>60 y.o.], sex,
and W. bancrofti Mf presence [negative vs. positive] and two contextual variables, namely ICT
prevalence by village of residence (four categories: <5, 5–10, 11–25,>25%), and a history of
recent MDA in the past 5 years (yes vs. no). The choice of ICT prevalence over FTS for this
analysis was because we were comparing the new test (FTS) to the older, reference test. The
model also considered the effect of district (5 groups) and village (28 groups). Because of a high
negative correlation between the ICT prevalence rates and the variable “history of MDA” (poly-
choric correlation coefficient = -0.70; p<0.001) [17], we performed one model with, and
another without the latter variable, to be sure that the ICT prevalence results were not distorted.
However, we found that inclusion or exclusion of “history of MDA” in the study area did not
significantly affect the results. The model was performed using STATA 14.0 (StataCorp, College
Station, TX). We also used two models to estimate the probability of microfilaremia based on
CFA scores (one model for the ICT, and one model for the FTS). First, we tested mixed multi-
variable models with the individual Mf result (negative vs. positive) as a dependent variable
with age, gender, endemicity, CFA scores, and history of recent MDA as explanatory variables.
These analyses also considered the potential influence of district and village on the results. An
interaction term between prior MDA and ‘CFA score’ variables was included (p<0.0001 and
p = 0.015 for ICT and FTS, respectively). Probabilities were then extracted using the command
margins, according to each CFA score, assuming mean values for the other variables. Third,
since school-aged children are a target population for the transmission assessment surveys
(TAS), we also performed a separate analysis for this sub-population (age10 years).
Ethical approval
These studies were embedded within in larger community studies of MDA efficacy. Protocols
for these studies were approved by ethics committees in each of the study countries. The pur-
poses of the study were presented during meetings with village leaders and then explained to
participants using an information sheet that was provided to each individual. Adult
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participants signed an informed consent form. Participants younger than 18 years of age were
enrolled only if they expressed verbal assent to participate in the study and at least one parent
signed a consent form.
Results
General population description
Test results from a total of 3,682 individuals were analyzed. Table 1 shows the number, median
age, and gender ratio of subjects tested at each site. Overall ICT and FTS prevalence rates were
24.5 and 26.4%, 15.6 and 17.2%, and 6.3 and 12.2% in the pre-MDA, post-MDA IVM+ALB,
and post-MDA ALB only study areas, respectively (Table 1). The overall Mf rate and the geo-
metric mean Mf density in people with antigenemia (detected by FTS) were 32.1% and 240.1
Mf/mL, 16.8% and 162.4 Mf/mL, and 11.9% and 27.8 Mf/mL, in the pre-MDA, post-MDA
IVM+ALB, and post-MDA ALB study areas, respectively.
Agreement between ICT and FTS results
Agreement percentages and Cohen’s κ scores are presented in Table 2, and FTS/ICT ratios are
shown in Table 1. Results for these three indicators were 96.7%, 0.89 (95% CI: 0.87–0.91) and
1.15, respectively, when data from all sites were considered together. The corresponding values
in pre-MDA sites (96.2%, 0.90 and 1.08) differed significantly from those obtained in post-
MDA sites (97.0%, 0.88 and 1.22) (p<0.001 for all three indicators) (Table 2). Cohen’s κ scores
differed widely between countries (0.78 in DRC, 0.92 in Coˆte d’Ivoire, 0.93 in Liberia and 0.64
in Congo). The overall pooled estimate of Cohen’s κ for data from the present study together
with published study data from Sri Lanka and Indonesia was 0.91 (95% CI: 0.87–0.95) (Fig 1).
The pooled estimate of Cohen’s κ was higher in pre-MDA sites [0.89 (95% CI: 0.82–0.96)],
than in the post-MDA ALB site [0.64 (95% CI: 0.53–0.74)] and the post-MDA DEC+ALB sites
[0.71 (95% CI: 0.47–0.95)] but lower than in the post-MDA IVM+ALB sites [0.9997 (95% CI:
0.9979–1.0015)]. Inclusion of random effects in the model showed that there was a high degree
of between-village heterogeneity (I2): 73.7% (p = 0.063), 56.8% (p = 0.088), and 85.5%
(p = 0.009) for the pre-MDA, post-MDA IVM+ALB, and post-MDA DEC+ALB study areas,
respectively. The estimate for post-MDA ALB alone was not possible due to a single data
source.
ICT/FTS discordance description
Only 14 subjects (0.4%) were ICT-positive and FTS-negative. Eleven of these cases were from
Coˆte d’Ivoire (pre-MDA), and four of the 12 individuals with this profile who provided night
blood were microfilaremic. Eight of the 14 individuals had an ICT score of 1 (including two
with Mf), four had an ICT score of 2 (one with Mf), one had an ICT score of 3 (Mf positive),
and one was positive with no score recorded. Conversely, 107 individuals (2.9%) were ICT-
negative but FTS-positive (“ICT-miss”), including 101, 5, and 1 with scores of 1, 2, and 3,
respectively. Six of these 107 individuals (6.3%) were Mf positive, and all 6 had a FTS score of
1; Mf counts were 16.7 (two subjects), 28.6, 50.0, 216.7, and 883.3 Mf/mL.
Comparison of ICT and FTS scores
FTS test scores in persons with positive test results were often higher than ICT scores (46.3%
in pre-MDA sites and 35.2% in post-MDA sites). These rates were not significantly different;
Mann-Whitney test, p = 0.275). If we consider antigen test scores for 598 subjects with positive
ICT and FTS tests, test scores were the same for 401 subjects (67.1%), and 186 subjects (31.1%)
Comparison of ICT and FTS tests for Wuchereria bancrofti antigenemia in Africa
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Table 1. Characteristics and indicators of W. bancrofti endemicity levels in all the sites where ICT and FTS were used in parallel in subjects.
















Liberia Total IVM+ALB 1,830 18 (10–40) 51.1 285 (15.6) 315 (17.2) 1.11 2 41 (16.8) 162.4 (102.2–257.9)
Foya IVM+ALB 681 14 (8–35) 48.5 78 (11.5) 81 (11.9) 1.04 2 0 NA
Harper IVM+ALB 1,149 22 (10–42) 52.6 207 (18.0) 234 (20.4) 1.13 0 41 (25.0) 162.4 (102.2–257.9)
Coˆte d’Ivoire Lagunes No 968 29 (15–47) 35.8 254 (26.2) 263 (27.2) 1.04 11 79 (30.4) 227.8 (164.0–316.6)
Congo Bouenza ALB 697 24 (10–43) 46.7 44 (6.3) 85 (12.2) 1.93 1 10 (11.9) 27.8 (13.4–57.5)
DRC Kwilu No 187 15 (10–35) 44.9 29 (15.5) 42 (22.5) 1.45 0 18 (42.9) 302.2 (105.1–869.0)
Total Pre-MDA - 1,155 28 (14–45) 37.3 283 (24.5) 305 (26.4) 1.08 11 97 (32.1) 240.1 (173.9–331.5)
Total Post-MDA - 2,527 20 (10–40) 49.9 329 (13.0) 400 (15.8) 1.22 3 51 (15.6) 114.8 (74.2–177.7)
Total all sites NA 3,682 23 (11–42) 45.9 612 (16.6) 705 (19.2) 1.15 14 148 (23.5) 186.2 (143.2–242.2)
Sri Lanka DEC+ALB 852 18 (2.1) 43 (5.1) 2.43 0 - -
Indonesia DEC+ALB 778 41 (5.3) 50 (6.4) 1.21 3 - -
DRC = Democratic Republic of Congo; MDA = Mass Drug Administration; ALB = albendazole; IVM = ivermectin; N = number of subjects examined;
IQR = Inter-quartile range; ICT+ = positive at the ICT test; FTS+ = positive at the FTS test; Mf+ = microfilaremic; GM = Geometric mean microfilarial density
(Mf/mL) among the microfilaremic individuals; 95%CI = 95% Confidence Interval; NA = not applicable.
& Liberia, Coˆte d’Ivoire, Congo, and DRC (new data included in this paper); Sri Lanka and Indonesia (data already published) [9].
$ Four MDA rounds both for Liberia and Congo sites.
* Percentage of microfilaremic individuals and GM among those with positive FTS.
https://doi.org/10.1371/journal.pntd.0005703.t001
Table 2. Cross-tabulation of filarial antigen test results (qualitative) obtained by the ICT and the FTS.
Sites No. of subjects according to ICT and FTS
results
Indicators of agreement
ICT+ ICT- Total Percentage of agreement Cohen’s κ coefficient (95% CI)
Total pre-MDA sites FTS+ 272 33 305
FTS- 11 839 850 96.2 0.900 (0.871–0.929)
Total 283 872 1,155
Coˆte d’Ivoire FTS+ 243 20 263
FTS- 11 694 705 96.8 0.918 (0.890–0.947)
Total 254 714 968
DRC FTS+ 29 13 42
FTS- 0 145 145 93.1 0.776 (0.661–0.890)
Total 29 158 187
Total post-MDA sites FTS+ 326 74 400
FTS- 3 2,124 2,127 97.0 0.877 (0.850–0.904)
Total 329 2,198 2,527
Liberia Harper (IVM+ALB) FTS+ 283 32 315
FTS- 2 1,513 1,515 97.7 0.924 (0.896–0.952)
Total 285 1,545 1,830
Liberia Foya (IVM+ALB) FTS+ 283 32 315
FTS- 2 1,513 1,515 99.0 0.950 (0.913–0.987)
Total 285 1,545 1,830
Congo (ALB alone) FTS+ 43 42 85
FTS- 1 611 612 93.8 0.636 (0.538–0.735)
Total 44 653 697
https://doi.org/10.1371/journal.pntd.0005703.t002
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had higher FTS scores. Besides the 14 ICT+/FTS- cases described above, 8 other subjects had
ICT scores that were higher than their FTS scores (Table 3).
Explicative factors for “ICT-miss” results (FTS positivity and ICT
negativity)
According to the individual-level model (Table 4), age and sex were not significantly associ-
ated with ICT-miss, whereas it was negatively associated with Mf positivity. Odds ratios
(OR) for ICT-miss were 0.16 for microfilaremic individuals, in both models with (95% CI:
Fig 1. Cohen’s Kappa score estimate obtained from a random-effects model. LH: Liberia Harper District. LF: Liberia Foya
District. CDI: Coˆte d’Ivoire. One village (Wetchoken, in the Harper district) from Liberia was not added in this analysis because all the
ICT were negative. "RE model" represents the pooled Cohen’s Kappa scores by group from the random-effects models.
https://doi.org/10.1371/journal.pntd.0005703.g001
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Table 3. Cross-tabulation of individual test scores obtained with the FTS and ICT.
All sites Pre-MDA Liberia Foya (Post-MDA)
ICT score ICT score
0 1 2 3 Total 0 1 2 3 Total
FTS score 0 839 6 4 1 850 598 7 0 0 599
1 30 74 1 0 105 3 15 2 0 20
2 3 75 45 1 124 1 3 22 2 28
3 0 6 30 40 76 1 0 2 30 33
Total 872 161 80 42 1,155 603 19 26 32 680
DRC (Pre-MDA) Liberia Harper (Post-MDA)
ICT score ICT score
0 1 2 3 Total 0 1 2 3 Total
FTS score 0 145 0 0 0 145 917 0 0 0 917
1 11 2 0 0 13 28 91 2 0 121
2 2 5 0 0 7 0 41 58 0 99
3 0 5 13 4 22 0 0 6 6 12
Total 158 12 13 4 187 945 132 66 6 1,149
Coˆte d’Ivoire (Pre-MDA) Congo (Post-MDA)
ICT score ICT score
0 1 2 3 Total 0 1 2 3 Total
FTS score 0 694 6 4 1 705 611 1 0 0 612
1 19 72 1 0 92 41 20 0 0 61
2 1 70 45 1 117 1 19 0 0 20
3 0 1 17 36 54 0 3 1 0 4
Total 714 149 67 38 968 653 43 1 0 697
https://doi.org/10.1371/journal.pntd.0005703.t003
Table 4. Results of the models exploring individual factors associated with ICT-miss (ICT-negative results in persons with positive FTS results).
MDA history not included in the
model
MDA history included in the
model
OR 95% CI p-value OR 95% CI p-value
Age (< 11 years old as reference) 11–20 0.58 0.16–2.02 0.388 0.54 0.15–1.91 0.338
21–40 0.87 0.27–2.79 0.811 0.82 0.25–2.66 0.743
41–60 0.77 0.23–2.59 0.672 0.74 0.22–2.50 0.627
>60 0.72 0.20–2.64 0.625 0.68 0.19–2.49 0.559
Sex (Female as reference) Male 0.90 0.54–1.49 0.678 0.91 0.55–1.51 0.716
Wuchereria bancrofti (Mf/mL) (0 Mf/mL as reference) Positive 0.16 0.06–0.40 <0.001 0.16 0.06–0.39 <0.001
Missing 1.23 0.46–3.28 0.685 1.39 0.50–3.85 0.527
ICT prevalence in the village of residence (>30% as reference) <10 26.73 4.02–177.58 0.001 37.05 5.26–360.8 <0.001
10–20 6.50 1.05–40.21 0.044 5.94 0.96–36.89 0.056
20–30 2.20 0.28–17.57 0.456 3.04 0.37–24.86 0.299
History of MDA in the village of residence (No MDA as reference) Yes NA NA NA 0.20 0.03–1.38 0.101
Intraclass correlation from district (2nd level)
Intraclass correlation from villages (3rd level)
13.8% 0.225 6.3% 0.425
21.0% <0.001 23.6% <0.001
https://doi.org/10.1371/journal.pntd.0005703.t004
Comparison of ICT and FTS tests for Wuchereria bancrofti antigenemia in Africa
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005703 September 11, 2017 9 / 15
0.06–0.39) and without MDA (95% CI: 0.06–0.40) as a variable. The risk of discordance was
also much higher for individuals living in communities with low ICT prevalence rates, with
OR of 26.73 (variable MDA not included) or 37.05 (variable MDA included) when the ICT
rate was <10%. This phenomenon is also illustrated in Fig 2, which shows the relationship at
community-level between the FTS/ICT ratio (an indicator of “ICT-miss” rates) and ICT
prevalence rate (including all the available data presented in Table 1). This figure shows that
there is a marked slope inflexion when the ICT rate is lower than 10%. Moreover, after
adjustment for Mf counts in individuals, the model suggests that prior MDA is not an inde-
pendent risk factor for ICT-miss. This is probably because Mf counts are strongly linked to
prior MDA. We also observed that the intraclass correlation (ICC) by village was not influ-
enced by the MDA history. The model revealed important heterogeneity between villages,
and approximately 20% of the variation in ICT-miss rates observed can be attributed to
unmeasured factors related to villages (ICC from villages of 21.0 and 23.6%, respectively, for
the model without MDA and with MDA; likelihood test ratio for both: p<0.0001); there
were no significant effects by district.
Comparison between results obtained in young children and older
individuals
Among 899 children (5–10 years old) examined in all the African study sites, only 36 (4.0%)
had positive ICT test results and 40 (4.5%) were positive by FTS (Table 5). The FTS/ICT ratio
in this sub-population (1.13) is similar to that found in the overall population (1.16) and in
those aged>10 years (1.15) (Table 5). The FTS/ICT ratios did not differ significantly between
children and older people (p = 0.744). Only one child (living in the untreated DRC site Misaie)
in this study was Mf positive, and both antigen tests were positive in this child.
Probability of microfilaremia by CFA test score
Fig 3 shows that the probability of microfilaremia was much higher in people with ICT or FTS
scores>1 in pre-MDA sites. Results were highly variable in post-MDA study sites. Details are
provided in S1 Table.
Discussion
The ability of the FTS to detect a lower concentration of filarial antigen in blood or serum than
the ICT has the potential to cause confusion for LF elimination programs, because current
thresholds for stopping MDA are based on community and school-aged children (transmis-
sion assessment survey) results obtained with the less sensitive ICT test [18]. This study was
designed to provide more information on the relative performance of the two antigen tests in
individuals and in communities before and after MDA. We analysed results obtained in five
sites located in four West and Central African countries. ICT and FTS were performed in par-
allel in 3,682 subjects, and 719 blood samples were positive by one or both of these tests. The
different situations between test sites regarding endemicity levels and history of MDA allowed
us to assess factors that are associated with discordant results that were observed in some indi-
viduals. We also analyzed differences in test scores between the two tests.
This study confirmed the superior sensitivity of FTS vs. ICT. The overall FTS/ICT ratio in
this study for pre-MDA settings (1.08) was slightly lower than a value previously reported
from Liberia (1.27) [7]. Similarly, FTS/ICT ratios (1.93, and 1.11 in post-MDA ALB, and post-
MDA IVM+ALB sites, respectively) were variable but generally consistent with previously
reported FTS/ICT ratios reported from post-MDA studies in Indonesia (1.22) and Sri Lanka
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(2.33) [9]. Different types of MDA could contribute to variability in FTS/ICT ratios and in
pooled Cohen’s κ coefficients in the Fig 1 because of their different effects on adult worms.
Multivariate analysis demonstrated that the risk of ICT-miss was related to the presence of
Mf in blood smears but not to age or sex. Only 6 of 107 ICT-miss subjects (ICT-/FTS+) were
microfilaremic. This represents only 0.2% of the total people studied, and all 6 of the Mf carri-
ers had FTS scores of 1. All four of the ICT+/FTS- subjects with microfilaremia lived in areas
Fig 2. Relationship between the ICT prevalence rate and the FTS/ICT ratio. All the data were included in
this figure: Liberia (Foya and Harper), Coˆte d’Ivoire (Soribadougou and Yadio), Congo, DRC, Sri Lanka, and
Indonesia (see Table 1 for details). Foya and Harper study areas comprised 9 and 15 villages, respectively.
Black symbols (post-MDA IVM+ALB), blue symbols (post-MDA DEC+ALB), green symbol (post-MDA ALB
alone), and pink symbols (pre-MDA).
https://doi.org/10.1371/journal.pntd.0005703.g002
Table 5. Results for antigenemia and microfilaremia according to age class and history of MDA.
No. tested ICT# FTS# FTS/ICT ratio No.TBS Mf+ ICT-/FTS+ ICT+/FTS-
No. (%) % Total pop. No. Mf+* No. Mf+&
All sites 5–10 y.o. 899 36 (4.0) 40 (4.5) 1.13 34 1 (2.9) 0.1 5 0 1 0
>10 y.o. 2,783 576 (20.7) 665 (23.9) 1.15 608 151 (24.8) 5.4 102 6 13 4
Pre-MDA 5–10 y.o. 160 7 (4.4) 9 (5.6) 1.27 9 1 (11.1) 0.6 2 0 0 0
>10 y.o. 995 276 (27.7) 296 (29.8) 1.08 303 100 (33.0) 10.1 31 1 11 4
Post-MDA 5–10 y.o. 739 29 (3.9) 31 (4.2) 1.08 25 0 0 3 0 1 0
>10 y.o. 1,788 300 (16.8) 369 (20.6) 1.23 305 51 (16.7) 2.9 71 5 2 0
* All the FTS were scored at 1. Eleven missing blood smears on the 107 ICT-/FTS+ individuals, from Soribadougou (Coˆte d’Ivoire) (2), and Foya (1) and
Harper (8) districts (Liberia).
& On the 4, two ICT were scored at 1, one at 2, and one at 3. Two missing blood smears on the 14 ICT+/FTS- individuals, from Soribadougou (Coˆte d’Ivoire),
and Foya district (Liberia).
# Number of positive tests and percentage.
https://doi.org/10.1371/journal.pntd.0005703.t005
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with no prior history of MDA. It is likely that the falsely negative FTS test results in these few
cases were due to technical problems with individual FTS strips (technical failures) or to opera-
tor error (e.g., too little blood being placed on the sample application pad). Moreover, methods
to perform the thick blood smears were different between Central Africa (two smears of 70 μL)
and West Africa (60 μL spread in three lines). This means that the lower limits of Mf detection
were approximately 17/mL and 7/mL for the studies in West Africa and in Central Africa,
respectively. While we may have underestimated Mf rates in the West African study sites, this
would not significantly affect the FTS/ICT comparisons.
The second main factor that influenced ICT-miss was the endemicity level in the village of
residence. The risk of ICT-miss increased as ICT rates decreased, and this was highly signifi-
cant for areas with ICT rates below 10%. This probably is due to reduced antigen levels in
areas with low endemicity following MDA that results in relatively more people with marginal
antigen levels that are detected by FTS but not by ICT. However, after adjusting for endemicity
level and Mf counts (infection intensity), we still observed high heterogeneity at the village
level (both using Cohen’s κ scores and with multilevel individual model). Such heterogeneity
was also noted by Yahathugoda et al. [9], and we cannot explain it at this time. Further
research would be needed to understand this observation.
FTS rates were slightly higher than ICT rates in children 5–10 years of age, just as they were
in older persons. However, only five children were FTS positive and ICT negative; after adjust-
ment for other variables, no difference was found between age groups regarding the frequency
of ICT-miss. These results are reassuring regarding the validity of previous transmission
assessment surveys (TAS) performed with ICT, and they suggest that evaluation units that pass
school-based TAS using ICT are also likely to pass if FTS are used instead of ICT cards.
It is interesting to consider the potential impact of the switch to FTS from ICT or Mf testing
for LF elimination programmes. First, more implementation units may be classified as
endemic for LF requiring MDA if FTS are used for mapping. Secondly, the higher sensitivity
of FTS raises the bar for pre-TAS surveys compared to Mf or ICT testing, and this could result
in additional rounds of MDA being required before evaluation units qualify for TAS. This
should reduce TAS failure rates. Finally, the higher sensitivity of FTS should make the test bet-
ter for early detection of recrudescence during post-MDA surveillance.
Our study focused on the comparison of sensitivity between two filarial antigen tests. How-
ever, it is also known that these tests are sometimes falsely positive due to crossreactivity in
Fig 3. Probability of microfilaremia by CFA score. The lines indicate the probabilities in the pre-MDA sites, and the dashed lines
the probabilities in the post-MDA sites with 95% confidence intervals.
https://doi.org/10.1371/journal.pntd.0005703.g003
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individuals with high intensity Loa loa infections [19–21]. Loiasis is not endemic in Coˆte
d’Ivoire or Liberia, and a preliminary survey of 200 persons in the DRC study site revealed no
loiasis cases. In Se´ke´ Pembe´ (Congo), thick blood smears performed by day on 181 subjects
showed that the prevalence of Loa microfilaremia was very low (2.2%), and the Mf densities in
the few people found infected were such (20–300 Mf/mL) that it is most unlikely they would
have influenced the ICT or FTS results. Both tests use the same reagents to detect the same
antigen, so there is no reason to think that FTS is more specific than the ICT. However, addi-
tional studies will be needed in areas with high rates of loiasis to directly address this issue.
Until then, the results presented in this paper should be considered to be valid for areas where
W. bancrofti is not coendemic with loiasis (i.e. the vast majority of LF-endemic areas in Africa
and around the world).
In conclusion, this study has provided extensive new information on the performance of
the FTS compared to ICT from studies performed in Africa. These studies confirmed that FTS
detects more people with CFA than the ICT test. However, the ratios of FTS/ICT vary in differ-
ent study sites, and this heterogeneity seems to be related to endemicity level, history of MDA,
and perhaps to the type of MDA used. These results suggest that FTS should be superior to
ICT for mapping, for TAS surveys, and for post-MDA surveillance.
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